Sinofn Unveils New Products and Strategic Engagements

Sinofn (Tianjin) Pharm-Tech Co., Ltd. has recently advanced its position in the medical nutrition sector with the launch of a new special diet for weight control. The company has also been appointed as a sub-center for the prevention of birth defects, underscoring its commitment to public health.

These developments indicate Sinofn's focus on innovation and its contribution to the healthcare landscape. The company has also actively engaged in strategic industry discussions, including a recent innovation dialogue in the Yunnan Dianzhong New Area. Such collaborations aim to foster advancements and new solutions within the sector.

Further demonstrating its commitment to quality and product integrity, Sinofn has highlighted the sourcing story of Ziziphus jujuba, emphasizing the origins of its functional ingredients. The company also keeps abreast of major pharmaceutical developments, such as the significant $18.5 billion alliance between AstraZeneca and CSPC Pharmaceutical Group for obesity drug innovation.

Sinofn's recent activities, including product introductions and participation in industry dialogues, solidify its role as a provider of specialized nutritional products and its engagement with the broader health and pharmaceutical industries.